Galanin-like peptide mRNA alterations in arcuate nucleus and neural lobe of streptozotocin-diabetic and Obese Zucker rats: Further evidence for leptin-dependent and independent regulation

Neuroendocrinology

Volumn 79, Issue 6, 2004, Pages 327-337

  Shen, Jun ^a,b   Gundlach, Andrew L ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Arcuate nucleus; Diabetes; Galanin receptors; Galanin like peptide; Leptin; Neuropeptide; Obesity; Pituicytes; Reproduction; Streptozotocin; Vasopressin

Indexed keywords

GALANIN LIKE PEPTIDE; GLUCOSE; LEPTIN RECEPTOR; MESSENGER RNA; NEUROPEPTIDE Y; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DEHYDRATION; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPOPHYSIS; HYPOTHALAMUS; MALE; NONHUMAN; OBESITY; OSMOREGULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SALT LOADING; VASOPRESSIN BLOOD LEVEL;

ANALYSIS OF VARIANCE; ANIMALS; ARCUATE NUCLEUS; ARGININE VASOPRESSIN; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; GALANIN-LIKE PEPTIDE; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MALE; NEUROPEPTIDE Y; OBESITY; PITUITARY GLAND; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER; RECEPTORS, CELL SURFACE; RNA, MESSENGER;

EID: 4444337712     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079752     Document Type: Article

References (55)

1. Merchenthaler I, Lopez FJ, Negro-Vilar A: Anatomy and physiology of central galanincontaining pathways. Prog Neurobiol 1993;40:711-769.
2. Chan YY, Grafstein-Dunn E, Delamere-van de Waal HA, Burton KA, Clifton DK, Steiner RA: The role of galanin and its receptor in the feedback regulation of growth hormone secretion. Endocrinology 1996;137:5303-5310.
3. Crawley J: The role of galanin in feeding behavior. Neuropeptides 1999;33:369-375.
4. Gundlach AL: Galanin/GALP and galanin receptors: Role in central control of feeding, body weight/obesity and reproduction? Eur J Pharmacol 2002;440:255-268.
5. Branchek TA, Smith KE, Gerald C, Walker MW: Galanin receptor subtypes. Trends Pharmacol Sci 2000;21:109-116.
6. Gustafson EL, Smith KE, Durkin MM, Gerald C, Branchek TA: Distribution of a rat galanin receptor mRNA in rat brain. Neuroreport 1996;7:953-957.
7. O'Donnell D, Ahmad S, Wahlestedt C, Walker P: Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: Distinct distribution from GALR1. J Comp Neurol 1999;409:469-481.
8. Mennicken F, Hoffert C, Pelletier M, Ahmad S, O'Donnell D: Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous system. J Chem Neuroanat 2002;24:257-268.
9. Ohtaki T, Kumano S, Ishibashi Y, Ogi K, Matsui H, Harada M, Kitada C, Kurokawa T, Onda H, Fujino M: Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus. J Biol Chem 1999;274:37041-37045.
10. Juréus A, Cunningham MJ, Li D, Johnson LL, Krasnow SM, Teklemichael DN, Clifton DK, Steiner RA: Distribution and regulation of galanin-like peptide (GALP) in the hypothalamus of the mouse. Endocrinology 2001;142:5140-5144.
11. Cunningham MJ, Scarlett JM, Steiner RA: Cloning and distribution of galanin-like peptide mRNA in the hypothalamus and pituitary of the macaque. Endocrinology 2002;143:755-763.
12. Juréus A, Cunningham MJ, McClain ME, Clifton DK, Steiner RA: Galanin-like peptide (GALP) is a target for regulation by leptin in the hypothalamus of the rat. Endocrinology 2000;141:2703-2706.
13. Larm JA, Gundlach AL: Galanin-like peptide (GALP) mRNA expression is restricted to arcuate nucleus of hypothalamus in adult male rat brain. Neuroendocrinology 2000;72:67-71.
14. Takatsu Y, Matsumoto H, Ohtaki T, Kumano S, Kitada C, Onda H, Nishimura O, Fujino M: Distribution of galanin-like peptide in the rat brain. Endocrinology 2001;142:1626-1634.
15. Friedman J, Halaas J: Leptin and the regulation of body weight in mammals. Nature 1998;395:763-770.
16. Ahima RS, Saper CB, Flier JS, Elmquist JK: Leptin regulation of neuroendocrine systems. Front Neuroendocrinol 2000;21:263-307.
17. Argiles JM: The obese Zucker rat: A choice for fat metabolism 1968-1988: Twenty years of research on the insights of the Zucker mutation. Prog Lipid Res 1989;28:53-66.
18. Harrdie LJ, Rayner DV, Holmes S, Trayhurn P: Circulating leptin levels are modulated by fasting, cold exposure and insulin administration in lean but not Zucker (fa/fa) rats as measured by ELISA. Biochem Biophys Res Commun 1996;223:660-665.
19. Chua SC Jr, White DW, Wu-Peng XS, Liu SM, Okada N, Kershaw EE, Chung LWK, Power-Kehoe M, Chua LA, Tartaglia L, Leibel RL: Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr). Diabetes 1996;45:1141-1143.
20. Porte D Jr, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, Schwartz MW: Obesity, diabetes and the central nervous system. Diabetologia 1998;41:863-881.
21. Hidaka S, Yoshimatsu H, Kondou S, Oka K, Tsuruta Y, Sakino H, Itateyama E, Noguchi H, Himeno K, Okamoto K, Teshima Y, Okeda T, Sakata T: Hypoleptinemia, but not hypoinsulinemia, induces hyperphagia in streptozotocin-induced diabetic rats. J Neurochem 2001;77:993-1000.
22. Shen J, Larm JA, Gundlach AL: Galanin-like peptide mRNA in neural lobe of rat pituitary. Increased expression after osmotic stimulation suggests a role for galanin-like peptide in neuron-glial interactions and/or neurosecretion. Neuroendocrinology 2001;73:2-11.
23. Fujiwara K, Adachi S, Usui K, Maruyama M, Matsumoto H, Ohtaki T, Kitada C, Onda H, Fujino M, Inoue K: Immunocytochemical localization of a galanin-like peptide (GALP) in pituicytes of the rat posterior pituitary gland. Neurosci Lett 2002;317:65-68.
24. Hatton GI: Astroglial modulation of neurotransmitter/ peptide release from the neurohypophysis: Present status. J Chem Neuroanat 1999;16:203-221.
25. Luo Y, Kaur C, Ling EA: Neuronal and glial response in the rat hypothalamus-neurohypophysis complex with streptozotocin-induced diabetes. Brain Res 2002;925:42-54.
26. Serino R, Ueta Y, Tokunaga M, Hara Y, Nomura M, Kabashima N, Shibuya I, Hattori Y, Yamashita H: Upregulation of hypothalamic nitric oxide synthase gene expression in streptozotocin-induced diabetic rats. Diabetologia 1998;41:640-648.
27. Dheen S, Tay S, Wong W: Arginine vasopressin- and oxytocin-like immunoreactive neurons in the hypothalamic paraventricular and supraoptic nuclei of streptozotocin-induced diabetic rats. Arch Histol Cytol 1994;57:461-472.
28. Sanacora G, Kershaw M, Finkelstein JA, White JD: Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and regulation by food deprivation. Endocrinology 1990;127:730-737.
29. McKibbin PE, Cotton SJ, McMillan S, Holloway B, Mayers R, McCarthy HD, Williams G: Altered neuropeptide Y concentrations in specific hypothalamic regions of obese (fa/fa) Zucker rats. Possible relationship to obesity and neuroendocrine disturbances. Diabetes 1991;40:1423-1429.
30. Sipols AJ, Baskin DG, Schwartz MW: Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 1995;44:147-151.
31. Yamashita T, Murakami T, Iida M, Kuwajima M, Shima K: Leptin receptor of Zucker fatty rat performs reduced signal transduction. Diabetes 1997;46:1077-1080.
32. Pu L-P, Van Leeuwen FW, Tracer HL, Sonnemans MAF, Loh YP: Localization of vasopressin mRNA and immunoreactivity in pituicytes of pituitary stalk-transected rats after osmotic stimulation. Proc Natl Acad Sci USA 1995;92:10653-10657.
33. Van Leeuwen FW, de Raaij C, Swaab D, Fisser B: The localization of oxytocin, vasopressin, somatostatin and luteinizing hormone-releasing hormone in the rat neurohypophysis. Cell Tissue Res 1979;202:189-202.
34. Kumano S, Matsumoto H, Takatsu Y, Noguchi J, Kitada C, Ohtaki T: Changes in hypothalamic expression levels of galanin-like peptide in rat and mouse models support that it is a leptin-target peptide. Endocrinology 2003;144:2634-2643.
35. Chinookoswong N, Wang J, Shi Z: Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes 1999;48:1487-1492.
36. Cheung CC, Clifton DK, Steiner RA: Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997;138:4489-4492.
37. Mizuno TM, Mobbs CV: Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 1999;140:814-817.
38. Vrang N, Kristensen P, Tang-Christensen M, Larsen PJ: Effects of leptin on arcuate proopiomelanocortin and cocaine-amphetamineregulated transcript expression are independent of circulating levels of corticosterone. J Neuroendocrinol 2002;14:880-886.
39. Hakansson M, Brown H, Ghilardi N, Skoda R, Meister B: Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 1998;18:559-572.
40. Cusin F, Rohner-Jeanrenaud A, Stricker-Krongrad, Jeanrenaud B: The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats. Reduced sensitivity compared with lean animals. Diabetes 1996;45:1446-1450.
41. Korner J, Chua SC Jr, Williams JA, Leibel RL, Wardlaw SL: Regulation of hypothalamic proopiomelanocortin by leptin in lean and obese rats. Neuroendocrinology 1999;70:377-383.
42. Havel P, Hahn T, Sindelar D, Baskin D, Dallman M, Weigle D, Schwartz M: Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes 2000;49:244-252.
43. Takenoya F, Funahashi H, Matsumoto H, Ohtaki T, Katoh S, Kageyama H, Suzuki R, Takeuchi M, Shioda S: Galanin-like peptide is colocalized with 4-melanocyte stimulating hormone but not with neuropeptide Y in the rat brain. Neurosci Lett 2002;331:119-122.
44. Hansen KR, Krasnow SM, Nolan MA, Fraley GS, Baumgartner JW, Clifton DK, Steiner RA: Activation of the sympathetic nervous system by galanin-like peptide - A possible link between leptin and metabolism. Endocrinology 2003;144:4709-4717.
45. Matsumoto Y, Watanabe T, Adachi Y, Itoh T, Ohtaki T, Onda H, Kurokawa T, Nishimura O, Fujino M: Galanin-like peptide stimulates food intake in the rat. Neurosci Lett 2002;322:67-69.
46. Lawrence CB, Baudoin FM-H, Luckman SM: Centrally administrated galanin-like peptide modifies food intake in the rat: A comparison with galanin. J Neuroendocrinol 2002;14:853-860.
47. Krasnow SM, Fraley GS, Schuh SM, Baumgartner JW, Clifton DK, Steiner RA: A role for galanin-like peptide in the integration of feeding, body weight regulation, and reproduction in the mouse. Endocrinology 2003;144:813-822.
48. Seth A, Stanley S, Dhillo W, Murphy K, Ghatei M, Bloom S: Effects of galanin-like peptide on food intake and the hypothalamo-pituitary-thyroid axis. Neuroendocrinology 2003;77:125-131.
49. Kyrkouli S, Stanley B, Leibowitz S: Galanin: Stimulation of feeding induced by medial hypothalamic injection of this novel peptide. Eur J Pharmacol 1986;122:159-160.
50. Smith BK, Berthoud HR, York DA, Bray GA: Differential effects of baseline macronutrient preferences on macronutrient selection after galanin, NPY, and an overnight fast. Peptides 1997;18:207-211.
51. Wang S, Ghibaudi L, Hashemi T, He S, Strader C, Bayne M, Davis H, Hwa JJ: The GalR2 galanin receptor mediates galanin-induced jejunal contraction, but not feeding behavior, in the rat: Differentiation of central and peripheral effects of receptor subtype activation. FEBS Lett 1998;434:277-282.
52. Poulain P, Decrocq N, Mitchell V: Direct inhibitory action of galanin on hypothalamic arcuate nucleus neurones expressing galanin receptor Gal-R1 mRNA. Neuroendocrinology 2003;78:105-117.
53. Fraley GS, Shimada I, Baumgartner JW, Clifton DK, Steiner RA: Differential patterns of Fos induction in the hypothalamus of the rat following central injections of galanin-like peptide and galanin. Endocrinology 2003;144:1143-1146.
54. Matsumoto H, Noguchi J, Takatsu Y, Horikoshi Y, Kumano S, Ohtaki T, Kitada C, Itoh T, Onda H, Nishimura O, Fujino M: Stimulation effect of galanin-like peptide (GALP) on luteinizing hormone-releasing hormone-mediated luteinizing hormone (LH) secretion in male rats. Endocrinology 2001;142:3693-3696.
55. Boersma CJC, Van Leeuwen FW: Neuron-glia interactions in the release of oxytocin and vasopressin from the rat neural lobe: The role of opioids, other neuropeptides and their receptors. Neuroscience 1994;62:1003-1020.